AzTrials
AzTrials

Esophageal AchalasiaNCT01742494

Comparison Study of Conventional POEM and Hybrid POEM for Esophageal Achalasia

A study testing Water-jet POEM and Conventional POEM in people with Esophageal Achalasia, run by Shanghai Zhongshan Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Peroral endoscopic myotomy (POEM) has recently been introduced as promising alternative to laparoscopic Heller myotomy for patients with idiopathic achalasia. Several technical modifications have been proposed but have not yet been tested in randomized trials. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Esophageal Achalasia
What is being tested?
Water-jet POEM and Conventional POEM
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteChina
Study dates
Aug 2011to Dec 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • With an Eckardt symptom score ≥ 4
  • The diagnosis of achalasia was made on the basis of the absence of peristalsis and on impaired relaxation of the LES on established methods (barium swallow, manometry, esophagogastroduodenoscopy)
  • Informed patient consent was obtained

Who cannot join

  • Severe cardiopulmonary disease or other serious disease leading to unacceptable surgical risk
  • Pseudoachalasia
  • Megaesophagus (diameter of > 7 cm)

Trial locations and contacts

1 site in 1 country.

Ping-Hong Zhou, M.D, PhD contact

86-13681971063

zhou1968@yahoo.cn

China1 site, 1 recruiting
  • Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University

    Shanghai, Shanghai Municipality, 200032

    Ping-Hong Zhou, MD,PhD

    Recruiting

Other trials in China

About this study

Official title: Peroral Endoscopic Myotomy for Esophageal Achalasia: Randomized Comparison of Water-Jet Assisted Versus Conventional Dissection Technique

Peroral endoscopic myotomy (POEM) has recently been introduced as promising alternative to laparoscopic Heller myotomy for patients with idiopathic achalasia. Several technical modifications have been proposed but have not yet been tested in randomized trials.

Read the detailed description

Objective: To evaluate efficacy and safety of water-jet assisted POEM (WJ) versus the conventional technique (C).

Interventions: Patients with achalasia diagnosed by symptoms, endoscopy and barium swallow eligible for POEM were randomized to either the use of Erbe Hybrid knife (WJ group) or the conventional technique using injection and triangle tip knife interchangeably (C group).

Main outcome measurements: Procedure time in both groups; secondary outcomes were clinical efficacy and safety (bleeding complications, pneumothorax or pleural effusion requiring intervention)

Being tested
Water-jet POEM, Conventional POEM
Keywords
Esophageal Achalasia,, Peroral endoscopic myotomy,, Water-jet assisted
Medical subject headings
Esophageal Achalasia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Water-jet POEMProcedure or surgery

    Water-jet assisted POEM procedure was performed

  • Conventional POEMProcedure or surgery

    POEM were performed by the use of conventional technique using injection and triangle tip knife.

Study groups in NCT01742494
Study groupRoleWhat they receive
Water-jet POEMActive comparatorPOEM were performed by the use of Erbe Hybrid knife (WJ group)
Receives: Procedure: Water-jet POEM
Conventional POEMActive comparatorPOEM were performed by the conventional technique using injection and triangle tip knife (C group).
Receives: Procedure: Conventional POEM

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Procedure time in both groups

    Measured: during POEM procedure

Secondary outcomes (1)
  1. clinical efficacy and safety

    bleeding complications, pneumothorax or pleural effusion requiring intervention

    Measured: during hospital stay and up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Dec 2012 (estimated)
  2. Study startAug 2011
  3. Primary completionApr 2012
  4. Study completionDec 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01742494
Sponsor's protocol ID
Hybrid POEM
Status last verified
Dec 2012
First submitted
20 Nov 2012
Last updated
5 Dec 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Cai MY, Zhou PH, Yao LQ, Xu MD, Zhong YS, Li QL, Chen WF, Hu JW, Cui Z, Zhu BQ. Peroral endoscopic myotomy for idiopathic achalasia: randomized comparison of water-jet assisted versus conventional dissection technique. Surg Endosc. 2014 Apr;28(4):1158-65. doi: 10.1007/s00464-013-3300-1.

    PubMed 24232052

Questions about this trial

What is this clinical trial studying?

A study testing Water-jet POEM and Conventional POEM in people with Esophageal Achalasia, run by Shanghai Zhongshan Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ping-Hong Zhou, M.D, PhD (86-13681971063, zhou1968@yahoo.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Procedure time in both groups (time frame: during POEM procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01742494, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in